Clinical Genomic Analyses Demonstrate t(11;14) Multiple Myeloma Retains B-Cell Biology and Distinct Mitochondrial Metabolism That Convey Increased Sensitivity to BCL-2 Inhibition By Venetoclax

威尼斯人 生物 多发性骨髓瘤 癌症研究 遗传学 分子生物学 免疫学 白血病 慢性淋巴细胞白血病
作者
David Sharon,Fengjiao Dunbar,Paul Jung,Xifeng Wang,Xiaotong Li,Christine Mantis,Orlando F. Bueno,Cyrille Touzeau,Philippe Moreau,Simon J. Harrison,Luciano J. Costa,Jonathan L. Kaufman,Nizar J. Bahlis,Shaji Kumar,Jeremy A. Ross,PK Epling-Burnette
出处
期刊:Blood [Elsevier BV]
卷期号:140 (Supplement 1): 4242-4244
标识
DOI:10.1182/blood-2022-160195
摘要

Introduction: Venetoclax (Ven) is a selective, potent, oral BCL-2 inhibitor under investigation as a targeted therapy for t(11;14)-positive relapsed/refractory multiple myeloma (RRMM). The molecular mechanisms underlying the increased sensitivity of t(11;14) MM to Ven have not been fully elucidated; however, remnants of B-cell biology and reduced cellular bioenergetics have been associated with sensitivity to Ven in MM. Transcriptomic analysis of 302 RRMM patient tumor cells before treatment with Ven-based regimens, an ex vivo B-cell differentiation model, and metabolic profiling of 7 MM cell lines were assessed to understand the unique biology that distinguishes t(11;14) in MM. Methods: CD138-enriched bone marrow mononuclear cells were collected at baseline from multiple Ven clinical trials (NCT02755597, NCT01794520, NCT03314181, NCT02899052). Biomarker analyses, including BCL2 gene expression by quantitative PCR, t(11;14) status by interphase fluorescence in situ hybridization (FISH), and transcriptomic analysis by RNA sequencing (RNA-seq), were performed by a central laboratory. Isolated healthy memory B-cells (MBCs) were progressively differentiated ex vivo into pre-plasmablast (Pre-PB), plasmablast (PB), and plasma cells (PC). MM cell lines were differentiated by treatment with all-trans retinoic acid (ATRA) for 3-days. Global metabolomic profiling was performed by liquid chromatography-mass spectrometry (LC-MS) in MM cell lines with or without ATRA-mediated differentiation. Gene set variation analysis (GSVA) was used to establish B-cell and mitochondrial (Mito) gene signatures. Results: Consistent with previous findings, t(11;14)-positive RRMM expressed significantly higher CCND1 (mean log2 FPKM: 3.8 vs −0.4, P<.0001) and BCL2 levels (mean 2-ΔCt: 1.3 vs 0.4, P<.0001) compared with t(11;14)-negative RRMM. Using a network-based enrichment map to interrogate differentially expressed genes, transcriptomes of t(11;14)-positive samples were enriched in several pathways, including cell cycle, metabolism and biosynthesis, and immune pathways. Significantly higher B-cell signature scores, but lower Mito signature scores were detected in t(11;14)-positive versus t(11;14)-negative RRMM patients (P<.0001; Figure). The ex vivo B-cell differentiation model confirmed that B-cell and Mito scores are differentiation-stage specific and significantly changed upon differentiation to plasma cells (P<.0001). In RRMM patients, there was an inverse correlation between the B-cell and Mito signature scores (R=−0.6, P<.0001). In vitro models were then used to further investigate the relationship between B-cell differentiation and Ven sensitivity. ATRA differentiated t(11;14)-positive MM cell lines, as indicated by lower expression of CD20 and increased expression of the plasma cell markers CD138 and CD38, significantly reduced BCL2 expression and increased basal rates of respiration in association with increased mitochondrial mass, which correlated with reduced Ven sensitivity. Differentially expressed metabolites were overrepresented in the purine biosynthetic pathway in t(11;14)-positive MM cell lines, which was corroborated by differential gene expression within this pathway in the ex vivo B-cell differentiation model and in t(11;14)-positive RRMM patients. Using thresholds that balance sensitivity and specificity of the B-cell and Mito signature scores associated with t(11;14)-positive RRMM, progression-free survival (PFS) outcomes in the BELLINI study were not superior to those demonstrated by t(11;14) or high BCL2 expression status alone (Table). Conclusions: Using an integrated approach of transcriptomic and metabolomic profiling, t(11;14) MM cells were confirmed to retain features of B-cell biology, including lower Mito metabolism that results in increased sensitivity to BCL-2 inhibition by Ven. Although these biological features are closely linked to t(11;14), B-cell gene or Mito gene signatures did not serve as better biomarkers for predicting efficacy to Ven compared with t(11;14) alone. Figure 1View largeDownload PPTFigure 1View largeDownload PPT Close modal
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
1秒前
Lucas应助lily采纳,获得10
1秒前
2秒前
烟花应助MADKAI采纳,获得10
2秒前
完美世界应助MADKAI采纳,获得10
2秒前
Andy1201应助MADKAI采纳,获得10
2秒前
赘婿应助MADKAI采纳,获得10
2秒前
3秒前
卡卡西应助缥缈麦片采纳,获得20
3秒前
zz完成签到,获得积分10
4秒前
4秒前
Hiyori完成签到,获得积分10
5秒前
蒋j发布了新的文献求助20
6秒前
6秒前
二喵发布了新的文献求助10
7秒前
7秒前
shs关闭了shs文献求助
7秒前
Lucas应助研友_Z345g8采纳,获得10
7秒前
8秒前
8秒前
9秒前
Amy完成签到,获得积分20
9秒前
pluto应助谷大喵唔采纳,获得10
9秒前
C胖胖完成签到,获得积分10
10秒前
香蕉觅云应助给我一块钱采纳,获得10
10秒前
乐乐应助机智听芹采纳,获得10
11秒前
美好雨竹发布了新的文献求助10
12秒前
Fandebiao发布了新的文献求助10
12秒前
12秒前
白菜发布了新的文献求助10
13秒前
14秒前
14秒前
东风龙完成签到,获得积分20
14秒前
Zzz_Carlos完成签到,获得积分10
15秒前
我是老大应助monoklatt采纳,获得10
15秒前
15秒前
cassie发布了新的文献求助10
17秒前
17秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3971277
求助须知:如何正确求助?哪些是违规求助? 3515939
关于积分的说明 11180280
捐赠科研通 3251061
什么是DOI,文献DOI怎么找? 1795664
邀请新用户注册赠送积分活动 875937
科研通“疑难数据库(出版商)”最低求助积分说明 805209